14th Jun 2021 13:04
FORM 8.3 Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 10 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,881,452 | 1.46% | 230,795 | 0.18% | ||
(2) | Derivatives (other than options): | ||||
72,359 | 0.06% | 94,581 | 0.07% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
| TOTAL: | |||||
1,959,911 | 1.52% | 331,476 | 0.26% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 2 | 258.1200 USD |
| Purchase | 7 | 256.2000 USD |
| Purchase | 96 | 256.3458 USD |
| Purchase | 100 | 256.5800 USD |
| Purchase | 100 | 259.0800 USD |
| Purchase | 100 | 259.1500 USD |
| Purchase | 170 | 256.6664 USD |
| Purchase | 380 | 257.9323 USD |
| Purchase | 400 | 256.8695 USD |
| Purchase | 621 | 258.0479 USD |
| Purchase | 632 | 258.2614 USD |
| Purchase | 1,425 | 258.0747 USD |
| Purchase | 1,630 | 257.2892 USD |
| Purchase | 2,088 | 258.2177 USD |
| Purchase | 2,795 | 257.5000 USD |
| Purchase | 3,324 | 257.4996 USD |
| Purchase | 5,790 | 257.4454 USD |
| Purchase | 9,601 | 258.8881 USD |
| Purchase | 13,546 | 257.6854 USD |
| Purchase | 14,050 | 258.0332 USD |
| Sale | 9 | 257.7200 USD |
| Sale | 18 | 257.8233 USD |
| Sale | 55 | 257.3800 USD |
| Sale | 70 | 257.9200 USD |
| Sale | 100 | 258.3100 USD |
| Sale | 100 | 257.3950 USD |
| Sale | 155 | 257.9700 USD |
| Sale | 162 | 257.7117 USD |
| Sale | 200 | 257.3750 USD |
| Sale | 300 | 257.8733 USD |
| Sale | 400 | 256.8695 USD |
| Sale | 550 | 258.1870 USD |
| Sale | 580 | 258.2054 USD |
| Sale | 601 | 257.3371 USD |
| Sale | 649 | 258.0523 USD |
| Sale | 869 | 257.3640 USD |
| Sale | 1,040 | 257.3584 USD |
| Sale | 1,346 | 257.3989 USD |
| Sale | 1,407 | 258.0779 USD |
| Sale | 1,549 | 257.5000 USD |
| Sale | 1,991 | 256.8376 USD |
| Sale | 2,009 | 257.2895 USD |
| Sale | 2,024 | 257.4051 USD |
| Sale | 3,324 | 257.4996 USD |
| Sale | 3,343 | 257.9917 USD |
| Sale | 4,158 | 257.5763 USD |
| Sale | 4,349 | 257.7358 USD |
| Sale | 11,853 | 258.0681 USD |
| Sale | 13,000 | 258.7619 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure | 14 June 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210614005407/en/
Copyright Business Wire 2021
Related Shares:
Barclays